real-time news and commentary for investors
Monday, Sep 10
2012, 11:18 AM
Biopharmaceutical company Cell Therapeutics (CTIC +6.9%) gains on optimism ahead of its...
Biopharmaceutical company Cell Therapeutics (CTIC +6.9%) gains on optimism ahead of its presentation tomorrow at the annual Rodman & Renshaw global investment conference. The company is slated to discuss the marketing plans for its non-Hodgkin's lymphoma treatment Pixuvri in the European Union, as well as update the status of clinical trials of pacritinib, including plans to initiate a phase III trial in Q4.